Salloum, Ramzi G and D'Angelo, Heather and Theis, Ryan P and Rolland, Betsy and Hohl, Sarah and Pauk, Danielle and LeLaurin, Jennifer H and Asvat, Yasmin and Chen, Li-Shiun and Day, Andrew T and Goldstein, Adam O and Hitsman, Brian and Hudson, Deborah and King, Andrea C and Lam, Cho Y and Lenhoff, Katie and Levinson, Arnold H and Prochaska, Judith and Smieliauskas, Fabrice and Taylor, Kathryn and Thomas, Janet and Tindle, Hilary and Tong, Elisa and White, Justin S and Vogel, W Bruce and Warren, Graham W and Fiore, Michael (2021) Mixed-methods economic evaluation of the implementation of tobacco treatment programs in National Cancer Institute-designated cancer centers. Implementation Science Communications, 2, (1), p. 41. doi: 10.1186/s43058-021-00144-7.
External website: https://implementationsciencecomms.biomedcentral.c...
BACKGROUND: The Cancer Center Cessation Initiative (C3I) was launched in 2017 as a part of the NCI Cancer Moonshot program to assist NCI-designated cancer centers in developing tobacco treatment programs for oncology patients. Participating centers have implemented varied evidence-based programs that fit their institutional resources and needs, offering a wide range of services including in-person and telephone-based counseling, point of care, interactive voice response systems, referral to the quitline, text- and web-based services, and medications.
METHODS: We used a mixed methods comparative case study design to evaluate system-level implementation costs across 15 C3I-funded cancer centers that reported for at least one 6-month period between July 2018 and June 2020.
RESULTS: The largest median operating cost category was personnel, with the highest personnel costs attributable to the provision of in-person program services. Monthly (non-zero) cost ranges for other categories were medications, materials, training, technology, and equipment. Median cost-per-participant was $466 and cost-per-quit was $2688, with sites offering different combinations of program components, ranging from individually-delivered in-person counseling only to one program that offered all components.
CONCLUSIONS: Among most centers that have progressed in tobacco treatment program implementation, cost-per-quit was modest relative to other prevention interventions. Although select centers have achieved similar average costs by offering program components of various levels of intensity, they have varied widely in program reach and effectiveness. Evaluating implementation costs of such programs alongside reach and effectiveness is necessary to provide decision makers in oncology settings with the important additional information needed to optimize resource allocation when establishing tobacco treatment programs.
G Health and disease > Pathologic process > Cancer
HJ Treatment or recovery method > Treatment outcome
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
MP-MR Policy, planning, economics, work and social services > Programme planning, implementation, and evaluation > Programme and budget analysis (cost benefit)
VA Geographic area > United States
Repository Staff Only: item control page